EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features

Julie Lourtet-Hascoët, Estibaliz Valdeolmillos, Ali Houeijeh, Eric Bonnet, Clément Karsenty, Shiv-Raj Sharma, Aleksander Kempny, Bernard Iung, Michael A Gatzoulis, Alain Fraisse, Sébastien Hascoët

Archives of Cardiovascular Diseases · 2023

DOI: 10.1016/j.acvd.2023.01.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Cardiovascular Diseases, 2023. Verfasst von Julie Lourtet-Hascoët und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology and Adults with Congenital Heart Disease Centre, Royal Brompton Hospital, SW3 6NP London, UK; Clinical Microbiolog…. Hauptthemen laut MEDLINE: Pulmonary Valve, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis, Endocarditis, Bacterial. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of transcatheter pulmonary valve implantation (TPVI) has greatly benefited the management of right ventricular outflow tract dysfunction. Infective endocarditis (IE) is a feared complication of TPVI that affects valve durability and patient outcomes. Current recommendations provide only limited guidance on the management of IE after TPVI (TPVI-IE). This article, by a group of experts in congenital heart disease in children and adults, interventional cardiology, infectious diseases including IE, and microbiology, provides a comprehensive review of the current evidence on TPVI-IE, including its incidence, risk factors, causative organisms, diagnosis, and treatment. The incidence of TPVI-IE varies from 13-91/1000 person-years for Melody valves to 8-17/1000 person-years for SAPIEN valves. Risk factors include history of IE, DiGeorge syndrome, immunosuppression, male sex, high residual transpulmonary gradient and portal of bacteria entry. Staphylococci and streptococci are the most common culprits, whereas Staphylococcus aureus is associated with the most severe disease. In addition to the modified Duke criteria, a high residual gradient warrants a strong suspicion. Imaging studies are helpful for the diagnosis. Intravenous antibiotics guided by blood culture results are the mainstay of treatment. Invasive re-intervention may be required. TPVI-IE in patients with congenital heart disease exhibits several distinctive features. Whether specific valve types are associated with a higher risk of TPVI-IE requires further investigation. Patient and parent education regarding IE prevention may have a role to play and should be offered to all patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary ValveHeart Valve Prosthesis ImplantationHeart Valve ProsthesisEndocarditis, BacterialEndocarditisHeart Defects, CongenitalAdultChildHumansMaleTreatment OutcomeCardiac CatheterizationRetrospective Studies

Stichwörter der Autor:innen

Congenital heart diseaseInfectionsInfective endocarditisInterventional cardiologyPulmonary valve

Autor:innen und Institutionen

  • Department of Pediatric Cardiology and Adults with Congenital Heart Disease Centre, Royal Brompton Hospital, SW3 6NP London, UK; Clinical Microbiology Laboratory, Hôpital Saint Joseph, Groupe Hospitalier Paris Saint Jos…
  • Pôle des cardiopathies congénitales, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Centre de Référence Cardiopathies Congénitales Complexes-réseau M3C, Faculté de Médecine, Université Paris-Saclay, I…
  • Department of Congenital Heart Disease, Lille University Hospital, 59000 Lille, France.
  • Infectious Diseases Mobile Unit, Clinique Pasteur, 31000 Toulouse, France.
  • Cardiologie pédiatrie, Hôpital des enfants, Centre de Compétence Cardiopathies Congénitales Complexes-réseau M3C- CHU Toulouse, 31000 Toulouse, France.
  • Department of Pediatric Cardiology and Adults with Congenital Heart Disease Centre, Royal Brompton Hospital, SW3 6NP London, UK.

Zitieren

APA

Lourtet-Hascoët, J., Valdeolmillos, E., Houeijeh, A., Bonnet, E., Karsenty, C., Sharma, S. R., Kempny, A., Iung, B., Gatzoulis, M. A., Fraisse, A., & Hascoët, S. (2023). Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2023.01.008

Vancouver

Lourtet-Hascoët J, Valdeolmillos E, Houeijeh A, Bonnet E, Karsenty C, Sharma SR, et al. Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features. Archives of Cardiovascular Diseases. 2023. doi:10.1016/j.acvd.2023.01.008

BibTeX
@article{LourtetHascot2023,
  author = {Lourtet-Hascoët, Julie and Valdeolmillos, Estibaliz and Houeijeh, Ali and Bonnet, Eric and Karsenty, Clément and Sharma, Shiv-Raj and Kempny, Aleksander and Iung, Bernard and Gatzoulis, Michael A and Fraisse, Alain and Hascoët, Sébastien},
  title = {Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features},
  journal = {Archives of Cardiovascular Diseases},
  year = {2023},
  doi = {10.1016/j.acvd.2023.01.008}
}
Kostenlos starten →